Muscle-targeted gene therapy reverses rare muscular dystrophy in mice ( ms of Pompe disease affect more than 5...)

Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

ms of Pompe disease affect more than 5,000 people in the U.S. If symptoms appear during infancy, the disease is usually fatal. Those for whom symptoms first appear late in childhood live longer, but life expectancy remains greatly decreased. Although Pompe disease is a relatively rare disease, it is but one of a group of related "lysosomal storage diseases," which in total occur in about one in 5,000 births.

The current study is part of a large, collaborative effort at Duke University Medical Center to find an effective treatment for Pompe disease. The Duke team earlier developed enzyme replacement therapy, in which a normal version of the faulty enzyme in those with the disease is infused weekly. In clinical trials of the replacement therapy, the infusions have already prolonged the lives of many babies with Pompe disease, Koeberl said.

"A number of babies have been receiving enzyme replacement therapy for several years," said Koeberl. "They are walking, living longer, and meeting developmental milestones."

Despite the early success of enzyme replacement therapy for some children with Pompe disease, a need for gene therapy remains, he added. In gene therapy, a therapeutic gene is delivered to patient cells, often using a modified virus.

Gene therapy might offer an alternative treatment for those children who fail to respond to enzyme replacement therapy, he said. Even for those that respond well to enzyme infusions, treatment requires weekly injection of a large amount of the enzyme.

"Gene therapy has the potential to reverse the course of the disease with a single treatment," Koeberl said.

The researchers delivered the glycogen-degrading enzyme with an adeno-associated virus (AAV) vector. AAV is not associated with any known human disease. The DNA coding for the enzyme was linked to a specialized DNA "promoter" region that restricted its activity to muscle. The investigators either injected the viral particles into t
'"/>

Source:Duke University Medical Center

Page: 1 2 3
Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. New therapy for HIV/AIDS eliminates needles and excessive toxicity
8. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
9. Gene therapy for Parkinsons disease moves forward in animals
10. Pulsating ultrasound enhances gene therapy for tumors
11. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

Post Your Comments:

( ms of Pompe disease affect more than 5...)Muscle-targeted gene therapy reverses rare muscular dystrophy in mice